Brief: Spectracure To Seek Approval For Clinical Study Of Primary Prostate Cancer

SpectraCure AB (publ)

16/11/2023 14:33

Nov 16 (Reuters) - SpectraCure AB (publ)  SPEC.ST :
    * SPECTRACURE HAS DECIDED TO SEEK APPROVAL FOR A CLINICAL
STUDY OF
PRIMARY PROSTATE CANCER
    * GOAL IS TO START CLINICAL STUDY IN FIRST HALF OF 2024

Source text for Eikon:  ID:nMFN8nVFzW 
Further company coverage:  SPEC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))